Understanding zika virus stability and developing a chimeric vaccine through functional analysis

mBio

Volumn 8, Issue 1, 2017, Pages

  Xie, Xuping ^a   Yang, Yujiao ^a,b   Muruato, Antonio E ^c   Zou, Jing ^a   Shan, Chao ^a   Nunes, Bruno T D ^a,d   Medeiros, Daniele B A ^a,d   Vasconcelos, Pedro F C ^d   Weaver, Scott C ^a,c   Rossi, Shannan L ^a,c   Shi, Pei Yong ^a,c  

^a University of Texas Medical Branch School of Medicine   (United States)

^b SOUTHWEST UNIVERSITY   (China)

^c UNIVERSITY OF TEXAS MEDICAL BRANCH   (United States)

^d INSTITUTO EVANDRO CHAGAS   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

NEUTRALIZING ANTIBODY; LIVE VACCINE; PRM PROTEIN, FLAVIVIRUS; VIRUS ENVELOPE PROTEIN; VIRUS VACCINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY RESPONSE; ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; DENGUE VIRUS 2; HYDROGEN BOND; LIMIT OF DETECTION; LIMIT OF QUANTITATION; MOUSE; NONHUMAN; PRM E GENE; THERMOSTABILITY; VIRUS GENE; VIRUS MORPHOLOGY; VIRUS PATHOGENESIS; ZIKA FEVER; ZIKA VIRUS; AMINO ACID SUBSTITUTION; ANIMAL; DENGUE; DENGUE VIRUS; DISEASE MODEL; DNA MUTATIONAL ANALYSIS; GENE DELETION; GENETIC RECOMBINATION; GENETICS; IMMUNOLOGY; ISOLATION AND PURIFICATION; PHYSIOLOGY; RADIATION RESPONSE; TEMPERATURE; VIRULENCE; VIRUS REPLICATION; ZIKA VIRUS INFECTION;

AMINO ACID SUBSTITUTION; ANIMALS; DENGUE; DENGUE VIRUS; DISEASE MODELS, ANIMAL; DNA MUTATIONAL ANALYSIS; MICE; RECOMBINATION, GENETIC; SEQUENCE DELETION; TEMPERATURE; VACCINES, ATTENUATED; VIRAL ENVELOPE PROTEINS; VIRAL VACCINES; VIRULENCE; VIRUS REPLICATION; ZIKA VIRUS; ZIKA VIRUS INFECTION;

EID: 85014811641     PISSN: 21612129     EISSN: 21507511     Source Type: Journal    
DOI: 10.1128/mBio.02134-16     Document Type: Article

References (29)

1. Dick GW, Kitchen SF, Haddow AJ. 1952. Zika virus. I. Isolations and serological specificity. Trans R Soc Trop Med Hyg 46:509–520. https://doi.org/10.1016/0035-9203(52)90042-4.
2. Petersen LR, Jamieson DJ, Powers AM, Honein MA. 2016. Zika virus. N Engl J Med 374:1552–1563. https://doi.org/10.1056/NEJMra1602113.
3. Shan C, Xie X, Barrett ADT, Garcia-Blanco MA, Tesh RB, Vasconcelos PF, Vasilakis N, Weaver SC, Shi PY. 2016. Zika virus: diagnosis, therapeutics, and vaccine. Infect Dis 2:170–172. https://doi.org/10.1021/acsinfecdis.6b00030.
4. Gourinat AC, O’Connor O, Calvez E, Goarant C, Dupont-Rouzeyrol M. 2015. Detection of Zika virus in urine. Emerg Infect Dis 21:84–86. https://doi.org/10.3201/eid2101.140894.
5. Musso D, Roche C, Nhan TX, Robin E, Teissier A, Cao-Lormeau VM. 2015. Detection of Zika virus in saliva. J Clin Virol 68:53–55. https://doi.org/10.1016/j.jcv.2015.04.021.
6. Nicastri E, Castilletti C, Liuzzi G, Iannetta M, Capobianchi MR, Ippolito G. 2016. Persistent detection of Zika virus RNA in semen for six months after symptom onset in a traveller returning from Haiti to Italy, February 2016. Euro Surveill 21:pii>30314. https://doi.org/10.2807/1560 -7917.ES.2016.21.32.30314.
7. Weaver SC, Costa F, Garcia-Blanco MA, Ko AI, Ribeiro GS, Saade G, Shi PY, Vasilakis N. 2016. Zika virus: history, emergence, biology, and prospects for control. Antiviral Res 130:69 – 80. https://doi.org/10.1016/j.antiviral.2016.03.010.
8. Foy BD, Kobylinski KC, Chilson Foy JL, Blitvich BJ, Travassos da Rosa A, Haddow AD, Lanciotti RS, Tesh RB. 2011. Probable non-vector-borne transmission of Zika virus, Colorado, USA. Emerg Infect Dis 17:880–882. https://doi.org/10.3201/eid1705.101939.
9. Mlakar J, Korva M, Tul N, Popović M, Poljšak-Prijatelj M, Mraz J, Kolenc M, Resman Rus K, Vesnaver Vipotnik T, Fabjan Vodušek V, Vizjak A, Pižem J, Petrovec M, Avšič Županc T. 2016. Zika virus associated with microcephaly. N Engl J Med 374:951–958. https://doi.org/10.1056/NEJMoa1600651.
10. Musso D, Nhan T, Robin E, Roche C, Bierlaire D, Zisou K, Shan Yan A, Cao-Lormeau VM, Broult J. 2014. Potential for Zika virus transmission through blood transfusion demonstrated during an outbreak in French Polynesia, November 2013 to February 2014. Euro Surveill 19:pii>20761. https://doi.org/10.2807/1560-7917.ES2014.19.14.20761.
11. Lindenbach BD, Murray CL, Thiel HJ, Rice CM. 2013. Flaviviridae, p 712–746. In Knipe M, Howley PM, Cohen JI, Griffin DE, Lamb RA, Martin MA, Racaniello VR, Roizman B (ed) Fields virology, 6th ed, vol. 1. Lippincott Williams & Wilkins, Philadelphia, PA.
12. Kostyuchenko VA, Lim EX, Zhang S, Fibriansah G, Ng TS, Ooi JS, Shi J, Lok SM. 2016. Structure of the thermally stable Zika virus. Nature 533: 425–428. https://doi.org/10.1038/nature17994.
13. Sirohi D, Chen Z, Sun L, Klose T, Pierson TC, Rossmann MG, Kuhn RJ. 2016. The 3.8 Å resolution cryo-EM structure of Zika virus. Science 352:467–470. https://doi.org/10.1126/science.aaf5316.
14. Kuhn RJ, Zhang W, Rossmann MG, Pletnev SV, Corver J, Lenches E, Jones CT, Mukhopadhyay S, Chipman PR, Strauss EG, Baker TS, Strauss JH. 2002. Structure of dengue virus: implications for flavivirus organization, maturation, and fusion. Cell 108:717–725. https://doi.org/10.1016/S0092 -8674(02)00660-8.
15. Mukhopadhyay S, Kim BS, Chipman PR, Rossmann MG, Kuhn RJ. 2003. Structure of West Nile virus. Science 302:248. https://doi.org/10.1126/science.1089316.
16. Goo L, Dowd KA, Smith ARY, Pelc RS, DeMaso CR, Pierson TC. 2016. Zika virus is not uniquely stable at physiological temperatures compared to other flaviviruses. mBio 7:e01396-16. https://doi.org/10.1128/mBio.01396-16.
17. Orozco S, Schmid MA, Parameswaran P, Lachica R, Henn MR, Beatty R, Harris E. 2012. Characterization of a model of lethal dengue virus 2 infection in C57BL/6 mice deficient in the alpha/beta interferon receptor. J Gen Virol 93:2152–2157. https://doi.org/10.1099/vir.0.045088-0.
18. Shan C, Xie X, Muruato AE, Rossi SL, Roundy CM, Azar SR, Yang Y, Tesh RB, Bourne N, Barrett AD, Vasilakis N, Weaver SC, Shi PY. 2016. An infectious cDNA clone of Zika virus to study viral virulence, mosquito transmission, and antiviral inhibitors. Cell Host Microbe 19:891–900. https://doi.org/10.1016/j.chom.2016.05.004.
19. Scaturro P, Cortese M, Chatel-Chaix L, Fischl W, Bartenschlager R. 2015. Dengue virus non-structural protein 1 modulates infectious particle production via interaction with the structural proteins. PLoS Pathog 11:e1005277. https://doi.org/10.1371/journal.ppat.1005277.
20. Xie X, Zou J, Puttikhunt C, Yuan Z, Shi PY. 2015. Two distinct sets of NS2A molecules are responsible for dengue virus RNA synthesis and virion assembly. J Virol 89:1298–1313. https://doi.org/10.1128/JVI.02882-14.
21. Patkar CG, Kuhn RJ. 2008. Yellow fever virus NS3 plays an essential role in virus assembly independent of its known enzymatic functions. J Virol 82:3342–3352. https://doi.org/10.1128/JVI.02447-07.
22. Lee E, Stocks CE, Amberg SM, Rice CM, Lobigs M. 2000. Mutagenesis of the signal sequence of yellow fever virus prM protein: enhancement of signalase cleavage in vitro is lethal for virus production. J Virol 74:24–32. https://doi.org/10.1128/JVI.74.1.24-32.2000.
23. Hamel R, Dejarnac O, Wichit S, Ekchariyawat P, Neyret A, Luplertlop N, Perera-Lecoin M, Surasombatpattana P, Talignani L, Thomas F, Cao-Lormeau VM, Choumet V, Briant L, Desprès P, Amara A, Yssel H, Missé D. 2015. Biology of Zika virus infection in human skin cells. J Virol 89: 8880–8896. https://doi.org/10.1128/JVI.00354-15.
24. Meertens L, Carnec X, Lecoin MP, Ramdasi R, Guivel-Benhassine F, Lew E, Lemke G, Schwartz O, Amara A. 2012. The TIM and TAM families of phosphatidylserine receptors mediate dengue virus entry. Cell Host Microbe 12:544–557. https://doi.org/10.1016/j.chom.2012.08.009.
25. Vannice KS, Durbin A, Hombach J. 2016. Status of vaccine research and development of vaccines for dengue. Vaccine 34:2934–2938. https://doi.org/10.1016/j.vaccine.2015.12.073.
26. Grant D, Tan GK, Qing M, Ng JK, Yip A, Zou G, Xie X, Yuan Z, Schreiber MJ, Schul W, Shi PY, Alonso S. 2011. A single amino acid in nonstructural protein NS4B confers virulence to dengue virus in AG129 mice through enhancement of viral RNA synthesis. J Virol 85:7775–7787. https://doi.org/10.1128/JVI.00665-11.
27. Zou G, Chen YL, Dong H, Lim CC, Yap LJ, Yau YH, Shochat SG, Lescar J, Shi PY. 2011. Functional analysis of two cavities in flavivirus NS5 polymerase. J Biol Chem 286:14362–14372. https://doi.org/10.1074/jbc.M110.214189.
28. Rossi SL, Tesh RB, Azar SR, Muruato AE, Hanley KA, Auguste AJ, Langs-joen RM, Paessler S, Vasilakis N, Weaver SC. 2016. Characterization of a novel murine model to study Zika virus. Am J Trop Med Hyg 94: 1362–1369. https://doi.org/10.4269/ajtmh.16-0111.
29. Zou G, Xu HY, Qing M, Wang QY, Shi PY. 2011. Development and characterization of a stable luciferase dengue virus for high-throughput screening. Antiviral Res 91:11–19. https://doi.org/10.1016/j.antiviral.2011.05.001.